David Bourdon

1.1k total citations · 1 hit paper
13 papers, 935 citations indexed

About

David Bourdon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David Bourdon has authored 13 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in David Bourdon's work include Cancer Genomics and Diagnostics (3 papers), Neuropeptides and Animal Physiology (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). David Bourdon is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Neuropeptides and Animal Physiology (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). David Bourdon collaborates with scholars based in United States, Australia and Norway. David Bourdon's co-authors include Pamela T. Manning, Mark G. Currie, Zhiqiang Wang, Margaret H. Marino, Daniela Salvemini, Daniela Salvemini, Michael Stern, John Sondek, Chester Costales and Wendy L. White and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

David Bourdon

11 papers receiving 899 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation

1996 590 citations Daniela Salvemini, Zhiqiang Wang et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Bourdon United States	6	346	265	182	158	120	13	935
Margaret H. Marino United States	8	328 0.9×	231 0.9×	120 0.7×	156 1.0×	93 0.8×	9	1.0k
James Truax United States	13	384 1.1×	205 0.8×	225 1.2×	277 1.8×	170 1.4×	25	1.2k
Jung Ok Ban South Korea	18	472 1.4×	223 0.8×	297 1.6×	189 1.2×	142 1.2×	24	1.3k
Teri L. Wadsworth United States	14	372 1.1×	296 1.1×	123 0.7×	198 1.3×	53 0.4×	17	1.1k
Dong Yeon Yuk South Korea	14	546 1.6×	395 1.5×	125 0.7×	168 1.1×	185 1.5×	17	1.5k
Sang Soo Sim South Korea	18	472 1.4×	97 0.4×	253 1.4×	136 0.9×	107 0.9×	40	1.1k
Anna Fiedorowicz Poland	12	421 1.2×	108 0.4×	263 1.4×	101 0.6×	117 1.0×	26	1.1k
Zhen‐Lun Gu China	26	794 2.3×	211 0.8×	152 0.8×	235 1.5×	140 1.2×	79	1.7k
Yue Hou China	25	662 1.9×	110 0.4×	300 1.6×	175 1.1×	103 0.9×	98	1.5k
Shailesh Dudhgaonkar India	15	327 0.9×	233 0.9×	96 0.5×	333 2.1×	190 1.6×	22	966

Countries citing papers authored by David Bourdon

Since Specialization

Citations

This map shows the geographic impact of David Bourdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bourdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bourdon more than expected).

Fields of papers citing papers by David Bourdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bourdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bourdon. The network helps show where David Bourdon may publish in the future.

Co-authorship network of co-authors of David Bourdon

This figure shows the co-authorship network connecting the top 25 collaborators of David Bourdon. A scholar is included among the top collaborators of David Bourdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bourdon. David Bourdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lam, Ernest T., et al.. (2024). A novel liquid biopsy assay for detection of ERBB2 (HER2) amplification in circulating tumor cells (CTCs). PubMed. 13(1). 27–35. 3 indexed citations

Bourdon, David, et al.. (2024). Abstract PO4-06-12: Distinction of basal-like and triple-negative basal-like breast cancers utilizing a novel comprehensive single-cell liquid biopsy-based test. Cancer Research. 84(9_Supplement). PO4–6.

Gupta, Santosh, David Bourdon, Anis Hamid, et al.. (2024). Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer. PubMed. 13(1). 1–6. 3 indexed citations

Lam, Ernest W.N., et al.. (2023). Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.. Journal of Clinical Oncology. 41(16_suppl). 3061–3061. 3 indexed citations

Scher, Howard I., Katherine Cunningham, Ethan Barnett, et al.. (2021). Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). e17039–e17039. 3 indexed citations

Bourdon, David, Chester Costales, Craig D. Wagner, et al.. (2011). Direct Activation of Human Phospholipase C by Its Well Known Inhibitor U73122. Journal of Biological Chemistry. 286(14). 12407–12416. 55 indexed citations

Bourdon, David, et al.. (2006). (N)‐methanocarba‐2MeSADP (MRS2365) is a subtype‐specific agonist that induces rapid desensitization of the P2Y1 receptor of human platelets. Journal of Thrombosis and Haemostasis. 4(4). 861–868. 18 indexed citations

Bourdon, David, et al.. (2006). Quantification of Isozyme‐Specific Activation of Phospholipase C‐β2 by Rac GTPases and Phospholipase C‐ɛ by Rho GTPases in an Intact Cell Assay System. Methods in enzymology on CD-ROM/Methods in enzymology. 406. 489–499. 22 indexed citations

Bourdon, David, Jean M. Camden, Linda A. Landon, Finn Olav Levy, & John T. Turner. (2000). Identification of the adenylyl cyclase‐activating 5‐hydroxytryptamine receptor subtypes expressed in the rat submandibular gland. British Journal of Pharmacology. 130(1). 104–108. 9 indexed citations

10.

Salvemini, Daniela, Zhiqiang Wang, David Bourdon, et al.. (1996). Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammation. British Journal of Pharmacology. 118(4). 829–838. 590 indexed citations breakdown →

11.

Salvemini, Daniela, Zhiqiang Wang, David Bourdon, et al.. (1996). Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. European Journal of Pharmacology. 303(3). 217–220. 227 indexed citations

12.

Bourdon, David. (1979). Calder: Mobilist, Ringmaster, Innovator. 1 indexed citations

13.

Bourdon, David. (1965). The Driftwood Aesthetic. Art Journal. 25(1). 26–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact